Patents by Inventor Rui Cerdeira de Campos Costa

Rui Cerdeira de Campos Costa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210322436
    Abstract: A pharmaceutical composition comprising licarbazepine acetate, especially eslicarbazepine acetate, in combination with suitable excipients, in particular a binder, and a disintegrant. Also disclosed is a granulation process, especially a wet granulation process, for making the pharmaceutical composition.
    Type: Application
    Filed: January 29, 2021
    Publication date: October 21, 2021
    Inventors: Teofilo Cardoso de Vasconcelos, Ricardo Jorge dos Santos Lima, Rui Cerdeira de Campos Costa
  • Publication number: 20210315824
    Abstract: The present disclosure relates to compositions and pharmaceutical formulations comprising at least one active pharmaceutical ingredient chosen from nitrocatechol derivatives of formula I as defined herein and salts, esters, hydrates, solvates and other derivatives thereof and methods of making the same.
    Type: Application
    Filed: December 15, 2020
    Publication date: October 14, 2021
    Applicants: BIAL - PORTELA & CA, S.A., BIAL - PORTELA & CA, S.A.
    Inventors: Teófilo Cardoso de Vasconcelos, Ricardo Jorge Jorge dos Santos Lima, Pedro Miguel da Costa Barrocas, Ligia Sofia de Castro Pereira, Rui Cerdeira de Campos Costa
  • Patent number: 10912781
    Abstract: A pharmaceutical composition comprising licarbazepine acetate, especially eslicarbazepine acetate, in combination with suitable excipients, in particular a binder, and a disintegrant. Also disclosed is a granulation process, especially a wet granulation process, for making the pharmaceutical composition.
    Type: Grant
    Filed: January 4, 2017
    Date of Patent: February 9, 2021
    Assignee: BIAL-Portela & C.A., S.A.
    Inventors: Teöfilo Cardoso de Vasconcelos, Ricardo Jorge dos Santos Lima, Rui Cerdeira de Campos Costa
  • Publication number: 20210023067
    Abstract: The present disclosure relates to compositions and pharmaceutical formulations comprising at least one active pharmaceutical ingredient chosen from nitrocatechol derivatives of formula I as defined herein and salts, esters, hydrates, solvates and derivatives thereof and methods of making said compositions and pharmaceutical formulations.
    Type: Application
    Filed: March 5, 2020
    Publication date: January 28, 2021
    Inventors: Teófilo Cardoso De Vasconcelos, Ricardo Jorge dos Santos Lima, Rui Cerdeira de Campos Costa
  • Patent number: 10583130
    Abstract: The present disclosure relates to compositions and pharmaceutical formulations comprising at least one active pharmaceutical ingredient chosen from nitrocatechol derivatives of formula I as defined herein and salts, esters, hydrates, solvates and derivatives thereof and methods of making said compositions and pharmaceutical formulations.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: March 10, 2020
    Assignee: BIAL-PORTELA & CA, S.A.
    Inventors: Teofilo Cardoso de Vasconcelos, Ricardo Jorge dos Santos Lima, Rui Cerdeira de Campos Costa
  • Publication number: 20190008774
    Abstract: The present disclosure relates to compositions and pharmaceutical formulations comprising at least one active pharmaceutical ingredient chosen from nitrocatechol derivatives of formula I as defined herein and salts, esters, hydrates, solvates and other derivatives thereof and methods of making the same.
    Type: Application
    Filed: September 5, 2018
    Publication date: January 10, 2019
    Inventors: Teófilo Cardoso de Vasconcelos, Ricardo Jorge dos Santos Lima, Pedro Miguel da Costa Barrocas, Ligia Sofia de Castro Pereira, Rui Cerdeira de Campos Costa
  • Publication number: 20180333402
    Abstract: The present disclosure relates to compositions and pharmaceutical formulations comprising at least one active pharmaceutical ingredient chosen from nitrocatechol derivatives of formula I as defined herein and salts, esters, hydrates, solvates and derivatives thereof and methods of making said compositions and pharmaceutical formulations.
    Type: Application
    Filed: July 31, 2018
    Publication date: November 22, 2018
    Inventors: Teofilo Cardoso de VASCONCELOS, Ricardo Jorge dos SANTOS LIMA, Rui Cerdeira de CAMPOS COSTA
  • Publication number: 20180256594
    Abstract: An oral suspension formulation comprising eslicarbazepine acetate and a pharmaceutically acceptable liquid vehicle.
    Type: Application
    Filed: October 17, 2017
    Publication date: September 13, 2018
    Inventors: Teófilo Cardoso de VASCONCELOS, Ricardo Jorge dos SANTOS LIMA, Rui Cerdeira de CAMPOS COSTA, Pedro Miguel da COSTA BARROCAS, Lígia Sofia de CASTRO PEREIRA
  • Patent number: 10071085
    Abstract: The present disclosure relates to compositions and pharmaceutical formulations comprising at least one active pharmaceutical ingredient chosen from nitrocatechol derivatives of formula I as defined herein and salts, esters, hydrates, solvates and derivatives thereof and methods of making said compositions and pharmaceutical formulations.
    Type: Grant
    Filed: August 13, 2015
    Date of Patent: September 11, 2018
    Assignee: BIAL—Portela & CA, S.A.
    Inventors: Teofilo Cardoso de Vasconcelos, Ricardo Jorge dos Santos Lima, Rui Cerdeira de Campos Costa
  • Publication number: 20170112850
    Abstract: A pharmaceutical composition comprising licarbazepine acetate, especially eslicarbazepine acetate, in combination with suitable excipients, in particular a binder, and a disintegrant. Also disclosed is a granulation process, especially a wet granulation process, for making the pharmaceutical composition.
    Type: Application
    Filed: January 4, 2017
    Publication date: April 27, 2017
    Inventors: Teofilo Cardoso de VASCONCELOS, Ricardo Jorge dos Santos Lima, Rui Cerdeira de Campos Costa
  • Patent number: 9566244
    Abstract: A pharmaceutical composition comprising licarbazepine acetate, especially eslicarbazepine acetate, in combination with suitable excipients, in particular a binder, and a disintegrant. Also disclosed is a granulation process, especially a wet granulation process, for making the pharmaceutical composition.
    Type: Grant
    Filed: December 17, 2013
    Date of Patent: February 14, 2017
    Assignee: BIAL-PORTELE & CA, S.A.
    Inventors: Teófilo Cardoso de Vasconcelos, Ricardo Jorge dos Santos Lima, Rui Cerdeira de Campos Costa
  • Publication number: 20150359783
    Abstract: The present disclosure relates to compositions and pharmaceutical formulations comprising at least one active pharmaceutical ingredient chosen from nitrocatechol derivatives of formula I as defined herein and salts, esters, hydrates, solvates and derivatives thereof and methods of making said compositions and pharmaceutical formulations.
    Type: Application
    Filed: August 13, 2015
    Publication date: December 17, 2015
    Inventors: Teofilo Cardoso de VASCONCELOS, Ricardo Jorge dos SANTOS LIMA, Rui Cerdeira de CAMPOS COSTA
  • Patent number: 9132094
    Abstract: The present disclosure relates to compositions and pharmaceutical formulations comprising at least one active pharmaceutical ingredient chosen from nitrocatechol derivatives of formula I as defined herein and salts, esters, hydrates, solvates and derivatives thereof and methods of making said compositions and pharmaceutical formulations.
    Type: Grant
    Filed: March 31, 2010
    Date of Patent: September 15, 2015
    Assignee: BIAL—Portela & Ca, S.A.
    Inventors: Teófilo Cardoso de Vasconcelos, Ricardo Jorge dos Santos Lima, Rui Cerdeira de Campos Costa
  • Publication number: 20140343043
    Abstract: A pharmaceutical composition comprising licarbazepine acetate, especially eslicarbazepine acetate, in combination with suitable excipients, in particular a binder, and a disintegrant. Also disclosed is a granulation process, especially a wet granulation process, for making the pharmaceutical composition.
    Type: Application
    Filed: December 17, 2013
    Publication date: November 20, 2014
    Applicant: BIAL - PORTELA & C.A., S.A.
    Inventors: Teófilo Cardoso de Vasconcelos, Ricardo Jorge dos Santos Lima, Rui Cerdeira de Campos Costa
  • Publication number: 20130040939
    Abstract: An oral suspension formulation comprising eslicarbazepine acetate and a pharmaceutically acceptable liquid vehicle.
    Type: Application
    Filed: September 10, 2010
    Publication date: February 14, 2013
    Applicant: BIAL - PORTELA & CA, S.A.
    Inventors: Teófilo Cardoso de Vasconcelos, Ricardo Jorge dos Santos Lima, Rui Cerdeira de Campos Costa, Pedro Miguel da Costa Barrocas, Ligia Sofia de Castro Pereira
  • Patent number: 8372431
    Abstract: A pharmaceutical composition comprising licarbazepine acetate, especially eslicarbazepine acetate, in combination with suitable excipients, in particular a binder, and a disintegrant. Also disclosed is a granulation process, especially a wet granulation process, for making the pharmaceutical composition.
    Type: Grant
    Filed: October 23, 2008
    Date of Patent: February 12, 2013
    Assignee: BIAL-Portela & C.A., S.A.
    Inventors: Teófilo Cardoso de Vasconcelos, Ricardo Jorge dos Santos Lima, Rui Cerdeira de Campos Costa
  • Publication number: 20100256193
    Abstract: The present disclosure relates to compositions and pharmaceutical formulations comprising at least one active pharmaceutical ingredient chosen from nitrocatechol derivatives of formula I as defined herein and salts, esters, hydrates, solvates and derivatives thereof and methods of making said compositions and pharmaceutical formulations.
    Type: Application
    Filed: March 31, 2010
    Publication date: October 7, 2010
    Applicant: BIAL - Portela & Ca, S.A.
    Inventors: Teófilo Cardoso de Vasconcelos, Ricardo Jorge dos Santos Lima, Rui Cerdeira de Campos Costa
  • Publication number: 20100256194
    Abstract: The present disclosure relates to compositions and pharmaceutical formulations comprising at least one active pharmaceutical ingredient chosen from nitrocatechol derivatives of formula I as defined herein and salts, esters, hydrates, solvates and other derivatives thereof and methods of making the same.
    Type: Application
    Filed: March 31, 2010
    Publication date: October 7, 2010
    Applicant: BIAL - Portela & Ca, S.A.
    Inventors: Teófilo Cardoso de Vasconcelos, Ricardo Jorge dos Santos Lima, Pedro Miguel da Costa Barrocas, Ligia Sofia de Castro Pereira, Rui Cerdeira de Campos Costa
  • Publication number: 20090110722
    Abstract: A pharmaceutical composition comprising licarbazepine acetate, especially eslicarbazepine acetate, in combination with suitable excipients, in particular a binder, and a disintegrant. Also disclosed is a granulation process, especially a wet granulation process, for making the pharmaceutical composition.
    Type: Application
    Filed: October 23, 2008
    Publication date: April 30, 2009
    Applicant: BIAL- Portela & Ca, S.A.
    Inventors: Teofilo Cardoso de Vasconcelos, Ricardo Jorge dos Santos Lima, Rui Cerdeira de Campos Costa